IL-36γ may, therefore, drive COPD pathophysiology via the recruitment and activation of neutrophils into the lung, leading to small airway remodeling, emphysema, and mucus hypersecretion (Figure 10). Here, IL36G is linked to chronic obstructive pulmonary disease.